Literature DB >> 33903645

The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.

Miho Kaminaga1, Junpei Komagamine2, Shinpei Tatsumi1.   

Abstract

No studies to investigate the effect of a deprescribing intervention on the occurrence of potential prescribing omissions (PPOs) among elderly patients with polypharmacy have been conducted. Therefore, the effect of deprescribing on PPOs among elderly patients with polypharmacy was investigated. All 121 consecutive elderly patients who received in-hospital deprescribing interventions were evaluated. The primary outcome was any occurrence of PPOs based on the 2015 STOPP/START criteria. The proportion of patients who had any PPOs significantly increased after the deprescribing interventions (52.9% vs 77.7%, p < 0.001). In the multivariable analysis, older age was the only independent risk factor associated with an increased risk of any PPOs after the deprescribing interventions (OR 1.08, 95% CI 1.01 to 1.16). In-hospital deprescribing interventions for elderly patients with polypharmacy may increase the occurrence of PPOs. Further study is warranted to investigate the effects on clinical outcomes of the increased occurrence of PPOs due to the deprescribing intervention.

Entities:  

Year:  2021        PMID: 33903645     DOI: 10.1038/s41598-021-88362-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  18 in total

Review 1.  Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.

Authors:  Janani Thillainadesan; Danijela Gnjidic; Sarah Green; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-04       Impact factor: 3.923

2.  Reducing inappropriate polypharmacy: the process of deprescribing.

Authors:  Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

3.  Does Deprescribing Improve Quality of Life? A Systematic Review of the Literature.

Authors:  Jennifer A Pruskowski; Sydney Springer; Carolyn T Thorpe; Michele Klein-Fedyshin; Steven M Handler
Journal:  Drugs Aging       Date:  2019-12       Impact factor: 3.923

Review 4.  Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.

Authors:  Eline Tommelein; Els Mehuys; Mirko Petrovic; Annemie Somers; Pieter Colin; Koen Boussery
Journal:  Eur J Clin Pharmacol       Date:  2015-09-26       Impact factor: 2.953

Review 5.  The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.

Authors:  Amy T Page; Rhonda M Clifford; Kathleen Potter; Darren Schwartz; Christopher D Etherton-Beer
Journal:  Br J Clin Pharmacol       Date:  2016-06-13       Impact factor: 4.335

6.  Hospital readmissions, mortality and potentially inappropriate prescribing: a retrospective study of older adults discharged from hospital.

Authors:  David Counter; James W T Millar; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2018-05-22       Impact factor: 4.335

Review 7.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.

Authors:  Denis O'Mahony; David O'Sullivan; Stephen Byrne; Marie Noelle O'Connor; Cristin Ryan; Paul Gallagher
Journal:  Age Ageing       Date:  2014-10-16       Impact factor: 10.668

8.  Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA).

Authors:  Rose Galvin; Frank Moriarty; Gráinne Cousins; Caitriona Cahir; Nicola Motterlini; Marie Bradley; Carmel M Hughes; Kathleen Bennett; Susan M Smith; Tom Fahey; Rose-Anne Kenny
Journal:  Eur J Clin Pharmacol       Date:  2014-02-04       Impact factor: 2.953

Review 9.  A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.

Authors:  Tariq M Alhawassi; Ines Krass; Beata V Bajorek; Lisa G Pont
Journal:  Clin Interv Aging       Date:  2014-12-01       Impact factor: 4.458

Review 10.  What is polypharmacy? A systematic review of definitions.

Authors:  Nashwa Masnoon; Sepehr Shakib; Lisa Kalisch-Ellett; Gillian E Caughey
Journal:  BMC Geriatr       Date:  2017-10-10       Impact factor: 4.070

View more
  1 in total

1.  Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH.

Authors:  Caroline de Godoi Rezende Costa Molino; Patricia O Chocano-Bedoya; Angélique Sadlon; Robert Theiler; John E Orav; Bruno Vellas; Rene Rizzoli; Reto W Kressig; John A Kanis; Sophie Guyonnet; Wei Lang; Andreas Egli; Heike A Bischoff-Ferrari
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.